The GI-MAP can be used in the detection and identification of gastrointestinal microbial nucleic acids and has been clinically validated for the detection of gastrointestinal pathogens that cause infectious colitis or gastroenteritis. This technology has been used to identify and control pathogen outbreaks because of its rapid turn-around-time.
It measures a substantial list of opportunistic pathogens as well as a list of FDA-cleared pathogens, including novel targets such as viruses, Microsporidia, and pathogenic virulence factors. Chronic gastrointestinal symptoms, intestinal permeability, hormonal imbalance, and food sensitivities may trace their origins to imbalanced gut microbes as a root cause.
Further, chronic inflammatory arthritis could have a microbial component that may warrant investigation by stool studies. This stool test offers integrative and functional medicine practitioners superior sensitivity and specificity to help resolve persistent and complex illnesses. Since the immune system, the intestinal barrier, and microbial diversity are intimately interwoven, thorough understanding of our gut microbiome holds promise for new approaches to treat and prevent disease.
Complete List of Target Analytes Measured on the GI-MAP
C. diff Toxin A & B**
E. coli o157**
Enterotoxigenic E. coli LT & ST (ETEC)**
Shiga-like Toxin producing E. coli stx1 & stx2 (STEC)**
Adenovirus 40 & 41**
Norovirus GI & GII**
Helicobacter pylori and virulence factors, cagA and vacA**
Bacteroides fragilis grp
E. coli (total)